NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 03 03:12PM ET
8.80
Dollar change
+0.26
Percentage change
3.04
%
IndexRUT P/E- EPS (ttm)-0.51 Insider Own16.62% Shs Outstand27.59M Perf Week6.28%
Market Cap243.06M Forward P/E10.65 EPS next Y0.83 Insider Trans-1.35% Shs Float23.08M Perf Month11.75%
Enterprise Value238.46M PEG- EPS next Q-0.04 Inst Own57.71% Short Float5.91% Perf Quarter48.15%
Income-14.07M P/S7.86 EPS this Y- Inst Trans-3.43% Short Ratio15.73 Perf Half Y42.86%
Sales30.91M P/B- EPS next Y391.67% ROA-24.35% Short Interest1.36M Perf YTD39.24%
Book/sh-0.21 P/C10.72 EPS next 5Y- ROE- 52W High8.72 0.92% Perf Year40.35%
Cash/sh0.82 P/FCF- EPS past 3/5Y71.16% 52.21% ROIC-115.34% 52W Low3.96 122.22% Perf 3Y51.20%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin90.27% Volatility4.21% 5.70% Perf 5Y-3.40%
Dividend TTM- EV/Sales7.71 EPS Y/Y TTM-620.97% Oper. Margin-38.76% ATR (14)0.44 Perf 10Y199.32%
Dividend Ex-Date- Quick Ratio4.97 Sales Y/Y TTM-31.23% Profit Margin-45.52% RSI (14)66.35 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio5.13 EPS Q/Q-110.22% SMA207.16% Beta0.40 Target Price12.80
Payout- Debt/Eq- Sales Q/Q-65.52% SMA5018.67% Rel Volume0.93 Prev Close8.54
Employees32 LT Debt/Eq- EarningsMay 13 BMO SMA20044.34% Avg Volume86.78K Price8.80
IPOOct 22, 2003 Option/ShortYes / Yes EPS/Sales Surpr.54.55% 8.05% Trades Volume80,323 Change3.04%
Date Action Analyst Rating Change Price Target Change
Nov-22-22Upgrade Cantor Fitzgerald Neutral → Overweight $9 → $12
Sep-07-22Initiated CapitalOne Overweight $11
Aug-08-22Resumed Craig Hallum Buy $14
Jun-05-20Initiated Cantor Fitzgerald Overweight $18
Oct-11-18Initiated Goldman Buy
Jun-03-25 04:31PM
May-14-25 10:51AM
03:07AM
May-13-25 11:33PM
11:06AM
07:15AM Loading…
07:15AM
06:03AM
May-12-25 05:10PM
May-09-25 06:26PM
May-08-25 06:05PM
04:17PM
May-07-25 05:35PM
Apr-30-25 09:55AM
Apr-10-25 09:35AM
Mar-21-25 10:21AM
03:00AM Loading…
Mar-11-25 03:00AM
12:31AM
Mar-10-25 06:03AM
Mar-06-25 04:22PM
Feb-07-25 07:00AM
Dec-20-24 06:16AM
Dec-19-24 06:13AM
Dec-12-24 07:01AM
Nov-13-24 06:27AM
Nov-09-24 02:00AM
Nov-07-24 06:13AM
Oct-31-24 06:23AM
Oct-28-24 06:23AM
Sep-05-24 06:56AM
Aug-14-24 01:57AM
06:05AM Loading…
Aug-13-24 06:05AM
Aug-06-24 04:31PM
Aug-05-24 06:26AM
Jul-29-24 06:15AM
Jul-15-24 08:32AM
Jul-01-24 06:00AM
Jun-25-24 04:35PM
May-15-24 08:44AM
May-14-24 10:53AM
07:20AM
06:03AM
May-07-24 06:15PM
Apr-23-24 08:01AM
Apr-05-24 07:00PM
Mar-27-24 07:00PM
Mar-26-24 01:00AM
Mar-22-24 09:49AM
05:04AM
Mar-21-24 02:52PM
06:00AM
Mar-19-24 10:14AM
06:01AM
Mar-17-24 09:00PM
Feb-29-24 07:04AM
Feb-01-24 05:55AM
Jan-06-24 03:01AM
Dec-05-23 05:55AM
Nov-09-23 04:50PM
Nov-07-23 09:40AM
02:10AM
Nov-06-23 05:59AM
Oct-30-23 06:45AM
Sep-07-23 05:59AM
Aug-10-23 12:53PM
Aug-03-23 05:59AM
Jul-31-23 05:30AM
Jun-12-23 05:00PM
Jun-08-23 02:53PM
Jun-06-23 05:44AM
May-11-23 06:01AM
May-08-23 06:15AM
Apr-28-23 09:26AM
Apr-01-23 08:12AM
Mar-31-23 08:03AM
Mar-30-23 05:55AM
Mar-24-23 06:30AM
Feb-23-23 08:44AM
Jan-31-23 06:00AM
Jan-25-23 07:19AM
Jan-23-23 11:57AM
Dec-17-22 09:55AM
Nov-11-22 07:10AM
Nov-01-22 10:28AM
Oct-17-22 08:00AM
Sep-26-22 07:35AM
Sep-21-22 02:19PM
01:05PM
07:00AM
06:05AM
Aug-22-22 07:04AM
Aug-12-22 06:59AM
Aug-01-22 02:59PM
07:30AM
Jul-10-22 08:42AM
Jun-14-22 06:00PM
May-23-22 07:29AM
May-12-22 06:00AM
May-06-22 05:17PM
May-03-22 09:55AM
Apr-27-22 06:00AM
Fennec Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of PEDMARK to reduce the risk of platinum-induced ototoxicity in pediatric patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROSTISLAV RAYKOVDirectorJul 03 '25Proposed Sale8.6110,00086,102Jul 03 02:01 PM
Raykov RostyDirectorJun 05 '25Sale7.7810,00077,80065,462Jun 06 04:20 PM
ROSTISLAV RAYKOVDirectorJun 05 '25Proposed Sale7.7810,00077,781Jun 05 04:31 PM
Andrade RobertCHIEF FINANCIAL OFFICERMay 22 '25Option Exercise5.108,22041,922158,520May 23 04:20 PM
Hackman Jeffrey S.Chief Executive OfficerMay 19 '25Buy6.9913,96597,61515,000May 19 05:42 PM
Hackman Jeffrey S.Chief Executive OfficerMay 16 '25Buy6.751,0356,9861,035May 19 05:42 PM
Raykov RostyDirectorMay 16 '25Sale6.7816,667113,00270,254May 19 04:30 PM
Raykov RostyDirectorMay 16 '25Proposed Sale6.0116,667100,169May 16 05:21 PM
Raykov RostyDirectorMay 05 '25Sale6.3110,00063,10053,587May 05 06:23 PM
ROSTISLAV RAYKOVDirectorMay 05 '25Proposed Sale6.3110,00063,078May 05 04:01 PM
Raykov RostyDirectorApr 04 '25Sale5.2510,00052,50061,156Apr 04 07:29 PM
ROSTISLAV RAYKOVDirectorApr 04 '25Proposed Sale5.2510,00052,537Apr 04 04:12 PM
Raykov RostyDirectorMar 05 '25Sale6.7910,00067,90068,725Mar 06 05:32 PM
ROSTISLAV RAYKOVDirectorMar 05 '25Proposed Sale6.7910,00067,930Mar 05 04:29 PM
RALLIS CHRIS ADirectorFeb 14 '25Option Exercise2.511,9925,00054,206Feb 14 06:13 PM
RALLIS CHRIS ADirectorFeb 14 '25Sale6.821,1868,08953,020Feb 14 06:13 PM
CHRIS A RALLISDirectorFeb 14 '25Proposed Sale6.821,1868,089Feb 14 04:03 PM
Raykov RostyDirectorFeb 05 '25Sale6.6610,00066,60076,294Feb 05 08:24 PM
ROSTISLAV RAYKOVDirectorFeb 05 '25Proposed Sale6.6610,00066,558Feb 05 04:42 PM
Raykov RostyDirectorJan 06 '25Sale6.0810,00060,80083,863Jan 07 05:15 PM
ROSTISLAV RAYKOVDirectorJan 06 '25Proposed Sale6.0810,00060,847Jan 06 04:19 PM
Raykov RostyDirectorDec 20 '24Option Exercise2.6925,00067,25091,432Dec 23 05:00 PM
Raykov RostyDirectorDec 05 '24Sale6.047964,80866,432Dec 05 04:24 PM
ROSTISLAV RAYKOVDirectorDec 05 '24Proposed Sale6.047964,808Dec 05 04:00 PM
Raykov RostyDirectorDec 03 '24Sale6.131,63510,02367,228Dec 04 05:20 PM
ROSTISLAV RAYKOVDirectorDec 03 '24Proposed Sale6.131,63510,023Dec 03 04:03 PM
RALLIS CHRIS ADirectorDec 02 '24Option Exercise2.6910,00026,90058,623Dec 02 07:07 PM
RALLIS CHRIS ADirectorDec 02 '24Sale6.146,40939,35152,214Dec 02 07:07 PM
CHRIS A RALLISDirectorDec 02 '24Proposed Sale6.146,40939,344Dec 02 04:06 PM
Andrade RobertCHIEF FINANCIAL OFFICERNov 18 '24Option Exercise2.4515,81638,749127,381Nov 18 05:02 PM
Raykov RostyDirectorNov 04 '24Sale4.312,43110,47866,432Nov 04 05:30 PM
ROSTISLAV RAYKOVDirectorNov 04 '24Proposed Sale4.312,43110,478Nov 04 04:02 PM
RALLIS CHRIS ADirectorOct 08 '24Option Exercise2.551,9604,99850,029Oct 10 05:14 PM
RALLIS CHRIS ADirectorOct 08 '24Sale4.531,4066,36948,623Oct 10 05:14 PM
Raykov RostyDirectorOct 01 '24Sale4.942,43112,00966,432Oct 01 05:11 PM
ROSTISLAV RAYKOVDirectorOct 01 '24Proposed Sale4.942,43112,009Oct 01 04:07 PM
Haigh AdrianDirectorSep 05 '24Proposed Sale5.0020,246101,230Sep 05 05:02 PM
Raykov RostyDirectorSep 04 '24Sale5.522,43113,41966,432Sep 04 06:48 PM
ROSTISLAV RAYKOVDirectorSep 04 '24Proposed Sale5.522,43113,419Sep 04 04:05 PM
ROSTISLAV RAYKOVOfficerAug 01 '24Proposed Sale6.262,43115,206Aug 01 04:21 PM
Raykov RostyCHIEF EXECUTIVE OFFICERAug 01 '24Sale6.252,43115,206187,471Aug 01 04:08 PM